In 2016, the France Bioproduction Congress was launched in the Centre-Val de Loire region. Today, it serves as the backdrop for an inspiring story: that of byoRNA, born from the meeting between Chantal Pichon, an mRNA expert at the University of Orléans–INSERM, and Thierry Ziegler, a specialist in biopharma industrialization (Merck, Sanofi, Cellectis).
How does a laboratory idea turn into an innovative company? Through 20 years of research on nucleic acids and 25 years of experience in bioproduction process development and industrialization—but also through decisive encounters at the France Bioproduction Congress. Together, they overcame the challenges of technology transfer and secured major funding (ARD Biomédicaments, France 2030, EIC Pathfinder and Transition).
On the occasion of the Congress’s 10th anniversary, they look back on their winding journey, from early regional support to recent successes. A discussion to understand how perseverance, partnerships, and key events transform innovation into reality—with all its difficulties and victories.
Their secret? Perseverance, networking, pivotal encounters at the France Bioproduction Congress, and an ecosystem capable of bringing companies to life despite the obstacles.
Join this roundtable to discover the details of their story and ask your questions.
